Pa, I., R, N., R, N., Ing, B., & K, T. (2018). DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR. Asian Journal of Pharmaceutical and Clinical Research, 11(1), 224–227. https://doi.org/10.22159/ajpcr.2018.v11i1.22125